Jump to content
  • Sign Up
×
×
  • Create New...
1 Vote = 0.10€ for server Owner!

Vertex’s CF Drug Demand Falters, Shaking Patient Confidence and Market Expectations

Pelican Press

By Pelican Press,
in World News

 Share

Recommended Posts

  • Diamond Member
Pelican Press Warlord

Pelican Press 0

Posted
  • Diamond Member
Posted

Bengaluru – Vertex Pharmaceuticals, a cornerstone in cystic fibrosis (CF) treatment, has reported quarterly results that fell short of Wall Street expectations, primarily due to weaker-than-anticipated demand for its flagship drug, Trikafta. The news has sent ripples of concern throughout the CF community, leaving patients and families questioning the stability and future of treatment access.

This is the hidden content, please

This is the hidden content, please

0

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
 Share
Go to topic listing

  • Vote for the server

    To vote for this server you must login.

    Jim Carrey Flirting GIF

  • Recently Browsing   0 members

    • No registered users viewing this page.

Important Information

Privacy Notice: We utilize cookies to optimize your browsing experience and analyze website traffic. By consenting, you acknowledge and agree to our Cookie Policy, ensuring your privacy preferences are respected.

  I accept